Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Overview of attention for article published in Lancet Infectious Diseases, December 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 17 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 165 X users
reddit: 1 Redditor

Citations

dimensions_citation: 153 Dimensions

Readers on

mendeley: 180 Mendeley

Summary News Blogs Policy documents X Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

User Bifobe, in the COVID-19 subreddit, 24 Dec 2021

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.